Perceptive Capital Solutions

FRNM · NASDAQ

$12.77−$0.33 (−2.52%)TodayMarket closed ·
Prev close $13.10

About FRNM

Perceptive Capital Solutions Corp is a US-based company operating in industry. The company is headquartered in New York City, New York. Perceptive Capital Solutions Corp is a blank check company. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The company may pursue an acquisition opportunity in any business, industry, sector or geographical location. The company intends to focus on industries that complement its management team’s background, and to capitalize on the ability of its management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries. In particular, the Company is targeting North American or European companies in the life sciences and medical technology sectors. The firm neither engaged in any operations nor generated any revenues.

Employees
0
Headquarters
New York City, New York
Listed
Jun 12, 2024
Sector
N/A
Industry
N/A

FRNM key statistics

Market cap
1.37B
Price-earnings ratio
1,310.00
Dividend yield
—
Average volume
714.00K
Volume
612.78K
Open price
$12.91
High today
$13.13
Low today
$12.48
52 Week high
$17.50
52 Week low
$9.95

Perceptive Capital Solutions (FRNM) at a glance

Perceptive Capital Solutions (FRNM) last traded at $12.77, with a market cap of 1.37B and a price-to-earnings ratio of 1310.00.

Today the stock has traded between $12.48 and $13.13. The current price is 2.3% above the day's low and 2.8% below its high.

Volume so far is 612.78K shares, in line with the average of 714.00K shares a day.

Over the past year Perceptive Capital Solutions has ranged from $9.95 to $17.50, and now sits 37% of the way up that range.

The average analyst price target is $18.36, 43.8% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 5 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 7 analystsAvg $18.36
Low
$17.17
Now
$12.77
High
$22.05

FRNM news

  • Chandrima Sanyal

    Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.